Where does CSL Behring AG rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), CSL Behring AG ranks #6,013 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does CSL Behring AG hold?

CSL Behring AG holds 56 US utility patents granted between 2015 and 2025, spanning 14 technology areas.

What is CSL Behring AG's Innovation Score?

CSL Behring AG has an Innovation Score of 44.4 out of 100 (top 26% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does CSL Behring AG focus on?

CSL Behring AG's top technology area is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations) with 48 patents, ranking #374 of 6,058 assignees active in that subclass. Grants appear in 14 CPC subclasses total.

Is CSL Behring AG's patent grant rate increasing or decreasing?

CSL Behring AG's recent grant velocity is -67% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for CSL Behring AG's patents?

CSL Behring AG's patents average 18.5 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the CSL Behring AG patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

CSL Behring AG

USPTO PatentsView assignee record - 56 granted patents across 14 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, CSL ranks #6,013 of 49,997 tracked US assignees by granted-patent volume, with 56 patents across 14 technology areas.

#6,013
of 49,997 US assignees by volume: Top 26%
by Innovation Score (44.4/100): 18.5
avg claims per patent: -67%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R6013 · Foreign Corporation #6,013 · 56 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-FRNCORP · VEL-DROP · BOOK-FULL

GRANTS-SMALL 56 grants
UPPER-Q #6,013/49,997
PHOTO-FINISH Anokiwave
CPC-FOCUS A61P · 14 areas
INNOV-PAR 44.4/100
CLAIMS-RICH 18.5 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-DROP -67% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Anokiwave, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How CSL’s 44.4 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 14.0 pts (32%) Velocity 6.1 pts (14%) Breadth 13.2 pts (30%) Claim depth 11.1 pts (25%)

Qualcomm Incorporated · highest

85
Corel · near

44
CSL Behring · this assignee

44
nVent Services · near

44
Shibuya · near

44
Vactronix Scientific · near

44
3D Lighting… · lowest

7

What this shows CSL's Innovation Score is 44.4/100 (top 26% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for CSL?

Each dot is one of CSL’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). CSL’s own 18.5 claims/patent is at or below the 19.4 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

CSL vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where CSL's grants concentrate

CSL Behring AG is a focused PatentsView assignee: 14 CPC subclasses with 85.7% of grants classified under A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations). Peak complete grant year is 2016 (13 grants) versus a trough of 1 in 2020. By volume, CSL sits between Anokiwave, Inc. and Check Point Software Technologies Ltd..

CSL's three-year grant acceleration

CSL Behring AG shows 10 grants in 2022–2024 against only 11 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Anokiwave

56
Bigo Technology P…

56
BRP US

56
Clover Network

56
Cyberlink

56
Caribou Bioscienc…

56
Certusview

56
Check Point Softw…

56
CSL Behring ◀

56

What this shows CSL holds 56 patents at rank #6,010, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near CSL

By rank, the assignees closest to #6,010 in granted patent volume.

Leaders in A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…)

Other assignees with the most granted patents in CSL's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for CSL, neither rank-band nor same-CPC leaders (those blocks stay above). In A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…), CSL ranks #374 of 6,058 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (44 here).

Vactronix Scientific, LLC 44 Corel Corporation 44 Shibuya Corporation 44 nVent Services GmbH 44

Similar claim depth

Nearest assignees by average claims per patent (18.5 here).

Simplify Medical Pty Ltd 18.5 avg Nanotronics Imaging, Inc. 18.5 avg Omnissa, LLC 18.5 avg Young Optics Inc. 18.5 avg

CSL's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

44 Top 26% higher than 74% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

CSL Behring AG patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	3	5.4%
2016	13	23.2%
2017	6	10.7%
2018	9	16.1%
2019	8	14.3%
2020	1	1.8%
2021	2	3.6%
2022	5	8.9%
2023	2	3.6%
2024	3	5.4%
2025partial year	4	7.1%

Which technologies does CSL Behring AG patent most?

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 48

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 48

C07K - Peptides 40

C12Y - Enzymes 9

B01D - Separation 6

Y02A - Technologies FOR Adaptation TO Climate Change 5

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 3

A61J - Containers Specially Adapted FOR Medical OR Pharmaceutical PURPOSES; Devices OR Methods Specially Adapted FOR Bringing Pharmaceutical Products Into Particular Physical OR Administering FORMS; Devices FOR Administering Food OR Medicines ORALLY; Baby COMFORTERS; Devices FOR Receiving Spittle 3

A61L - Methods OR Apparatus FOR Sterilising Materials OR Objects IN GENERAL; Disinfection, Sterilisation OR Deodorisation OF AIR; Chemical Aspects OF Bandages, Dressings, Absorbent Pads OR Surgical ARTICLES; Materials FOR Bandages, Dressings, Absorbent Pads OR Surgical Articles 2

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 2

B65D - Containers FOR Storage OR Transport OF Articles OR Materials, e.g. Bags, Barrels, Bottles, Boxes, Cans, Cartons, Crates, Drums, Jars, Tanks, Hoppers, Forwarding CONTAINERS; Accessories, Closures, OR Fittings THEREFOR; Packaging ELEMENTS; Packages 1

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 1

B05B - Spraying APPARATUS; Atomising APPARATUS; Nozzles 1

A61B - DIAGNOSIS; SURGERY; Identification 1

Top 14 of 14 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

CSL Behring AG's patent record in context - here's where to go next.

CSL Behring AG's lead technology class is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations), 85.7% of its portfolio - see every assignee active in that class. Explore A61P
Ranked #6,013 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare CSL Behring AG against Anokiwave, Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 44.4/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.